(2S,3S,4S,5R,6R)-6-(1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)ureido)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid-13CD3
Regorafenib-13C-d3 N-Glucuronide (M7 Metabolite) is a fully characterized chemical compound used as a reference standard of API Regorafenib. The standard offered is compliant with regulatory guidelines. Regorafenib-13C-d3 N-Glucuronide (M7 Metabolite) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - N/A
